Recombinant Antibodies for Cancer Therapy Methods and Protocols /

Detalles Bibliográficos
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Welschof, Martin. (Editor ), Krauss, Jürgen. (Editor )
Formato: eBook
Lenguaje:English
Publicado: Totowa, NJ : Humana Press : Imprint: Humana, 2003.
Edición:1st ed. 2003.
Colección:Methods in Molecular Biology, 207
Materias:
Acceso en línea:https://doi.org/10.1385/1592593348
Tabla de Contenidos:
  • Generation of Antibody Molecules Through Antibody Engineering
  • Application of Recombinant Antibodies in Cancer Patients
  • Hybridoma-Derived Antibodies
  • DNA Immunization as a Means to Generate Antibodies to Proteins
  • Chimerization of a Monoclonal Antibody for Treating Hodgkin's Lymphoma
  • Humanization of Monoclonal Antibodies by CDR Grafting
  • Recombinant Antibody Fragments from Phagemid-Displayed Antibody Repertoires
  • Generation and Screening of a Modular Human scFv Expression Library from Multiple Donors
  • Construction of Semisynthetic Antibody Libraries
  • Single-Domain VH Antibody Fragments from a Phage Display Library
  • Isolation of Human Fab Fragments Against Ovarian Carcinoma Using Guided Selection
  • Human Recombinant Fab Antibodies with T-Cell Receptor-Like Specificities Generated from Phage Display Libraries
  • Engineering Hot Spots for Affinity Enhancement of Antibodies
  • Simultaneous Humanization and Affinity Optimization of Monoclonal Antibodies
  • Tailoring Kinetics of Antibodies Using Focused Combinatorial Libraries
  • Antibody Fragments with Additional Properties
  • Engineering scFvs for Improved Stability
  • Recombinant Single-Chain and Disulfide-Stabilized Fv Immunotoxins for Cancer Therapy
  • Generation of Recombinant Immunotoxins for Specific Targeting of Tumor-Related Peptides Presented by MHC Molecules
  • Construction and Characterization of RNase-Based Targeted Therapeutics
  • Bispecific Diabodies for Cancer Therapy
  • Generation and Characterization of Bispecific Tandem Diabodies for Tumor Therapy
  • Generation of Recombinant Multimeric Antibody Fragments for Tumor Diagnosis and Therapy
  • Construction and Characterization of Minibodies for Imaging and Therapy of Colorectal Carcinomas
  • Generation, Expression, and Monitoring of Recombinant Immune Receptors for Use in Cellular Immunotherapy
  • Tailoring Natural Effector Functions
  • Single-Chain Fv-Based Affinity Purification of the Cellular Stress Protein gp96 for Vaccine Development
  • Recombinant Adenoviruses for In Vivo Expression of Antibody Fragments
  • Large Scale Production of Recombinant Antibodies for Clinical Application
  • Production of Antibody Fragments in a Bioreactor
  • Large Scale Production of Recombinant Antibodies by Utilizing Cellulose-Binding Domains
  • Production of Tumor-Specific Antibodies in Tobacco.